Bacteriophage Therapy in Intensive Care Units: A Targeted Strategy to Combat Multidrug-Resistant Infections – A Review
Premier Journal of Science · 13.10.2025
DOI: 10.70389/pjs.100120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Premier Journal of Science, online erschienen am 13.10.2025. Verfasst von Vishnuprasadh Azhagiya Manavalan und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Intensivpflege
Abstract (Originalsprache)
The rise of multidrug-resistant (MDR) bacterial infections, particularly in intensive care units (ICUs), poses a grave threat to global health, severely compromising the effectiveness of conventional antibiotics. This crisis has been further exacerbated by the COVID-19 pandemic, which led to the indiscriminate use of broad-spectrum antimicrobials and heightened susceptibility to secondary infections. In this context, bacteriophage (phage) therapy has re-emerged as a promising, targeted alternative capable of addressing MDR infections in critical care settings. Unlike traditional antibiotics, phages exhibit narrow host specificity, the ability to penetrate biofilms, and self-replicating potential at the infection site, making them ideal candidates for ICU integration. This review explores the therapeutic promise of phage therapy in ICU protocols, emphasizing strategies such as phage-antibiotic synergy (PAS), personalized phage cocktails, and engineered phages. It also highlights clinical evidence supporting phage efficacy, regulatory and infrastructural challenges, and the diagnostic tools required for effective implementation. Finally, the review argues for the integration of phage therapy as part of a forward-looking, One Health–aligned strategy to mitigate antimicrobial resistance and improve patient outcomes in ICU environments.
Zitieren
APA
Manavalan, V. A., Vinayagam, S., Sundaram, T., Chopra, S., Chopra, H., & Malik, T. (2025). Bacteriophage Therapy in Intensive Care Units: A Targeted Strategy to Combat Multidrug-Resistant Infections – A Review. Premier Journal of Science. https://doi.org/10.70389/pjs.100120
Vancouver
Manavalan VA, Vinayagam S, Sundaram T, Chopra S, Chopra H, Malik T. Bacteriophage Therapy in Intensive Care Units: A Targeted Strategy to Combat Multidrug-Resistant Infections – A Review. Premier Journal of Science. 2025. doi:10.70389/pjs.100120
BibTeX
@article{Manavalan2025,
author = {Manavalan, Vishnuprasadh Azhagiya and Vinayagam, Saranya and Sundaram, Thanigaivel and Chopra, Shivani and Chopra, Hitesh and Malik, Tabarak},
title = {Bacteriophage Therapy in Intensive Care Units: A Targeted Strategy to Combat Multidrug-Resistant Infections – A Review},
journal = {Premier Journal of Science},
year = {2025},
doi = {10.70389/pjs.100120}
}
EUVIMED